Clinical Trials Browser

Liver Neoplasms

Pancreatic Neoplasms

Pancreatic Cystic Neoplasm

Brain Neoplasms, Melanoma, Pancreatic Neoplasms

Pancreatic Neoplasms

CLDN18.2 Positive

Pancreatic cancer, adult

Pancreatic Neoplasms

Advanced Biliary Tract Cancer(BTC)

Pancreatic Neoplasms

Pancreatic Neoplasms

Pancreatic Neoplasms

Pancreatic Cancer Resectable

CLDN18.2-positive Advanced Biliary Tract Cancer

Pancreatic Neoplasms

Biliary Tract Neoplasms

PDAC - Pancreatic Ductal Adenocarcinoma

Bile Duct Neoplasms, Biliary Tract Neoplasms, Cholangiocarcinoma, Klatskin Tumor

Biliary Tract Neoplasms

Cholangiocarcinoma, Klatskin Tumor

Biliary Tract Neoplasms, Cholangiocarcinoma

Pancreatic Cancer Resectable

Biliary Tract Neoplasms

Pancreatic Neoplasms

Bile Duct Neoplasms

Pancreatic Neoplasms

Pancreatic Neoplasms

Gallbladder Cancer Unresectable

Pancreatic Neoplasms

Biliary Tract Neoplasms

Cholangiocarcinoma

Pancreatic Neoplasms

Pancreatic Neoplasms

Pancreatic Neoplasms

Anophthalmia with pulmonary hypoplasia, Pancreatic Neoplasms

Pancreatic Neoplasms

Pancreatic Neoplasms

Locally Advanced Pancreatic Cancer

Pancreatic Neoplasms

Pancreatic Neoplasms

Clinical Trials

A Phase II Study of Single Tremelimumab With Regular Interval Durvalumab Plus Gemcitabine and Cisplatin in Locally Advanced Unresectable/Metastatic Combined Hepatocellular-cholangiocarcinoma

ANO31905 in Combination With Chemotherapy for CLDN18.2-Positive Locally Advanced Unresectable or Metastatic Pancreatic Cancer

Endoscopic Ultrasound-Guided Chemoablation for the Treatment of Pancreatic Cysts

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

ResQ108B-PANC

IBI343 in Combination Therapy for Advanced Malignant Solid Tumors

Surufatinib Plus Gemcitabine and Nab-paclitaxel vs. Gemcitabine Plus Nab-paclitaxel in Neoadjuvant Therapy for High - Risk Resectable or Borderline Resectable Pancreatic Cancer

A Study of FG-M108+Chemotherapy vs Placebo+Chemotherapy in Claudin18.2-positive Pancreatic Cancer

NOBLE

PTCA199-16

Phase III Study to Compare GFH375 and Chemotherapy in Patients With KRAS G12D-Mutant Metastatic Pancreatic Cancer

Adebrelimab Combined With Chemotherapy for Neoadjuvant Therapy in Resectable Pancreatic Cancer

LEFT-PANC

Combination of QLS31905 and Chemotherapy ± QL2107 in Patients With CLDN18.2-positive Advanced Biliary Tract Cancer

Efficacy and Safety of LM-302 Combined With Gemcitabine CLDN 18.2 Positive Unresectable Locally Advanced or Metastatic Pancreatic Cancer

The Safety and Efficacy of Benmelstobart Injection in Patients With Advanced Biliary Tract Malignant Tumors

PANORAMIX

Phase II Study of Neoadjuvant Tislelizumab Plus Radiotherapy and GP Chemotherapy for Borderline/Unresectable Hilar Cholangiocarcinoma

Envafolimab With Chemotherapy and Simvastatin in Advanced Biliary Tract Cancer

NEODISCO

TisGCS for BTC

Personalized Tumor Neoantigen MRNA Therapy Adjuvant Treatment for Postoperative Pancreatic Cancer.

Inetetamab Plus Chemotherapy ± PD-1/PD-L1 in HER2+ Advanced Biliary Cancer

Neoadjuvant/Adjuvant Sintilimab, Nab-paclitaxel, and Gemcitabine for Resectable/Borderline Resectable Pancreatic Cancer

Ablatio

YL-13027 and/or HY-0102 Combined With AG Regimen Chemotherapy for Metastatic Pancreatic Cancer

Anlotinib Plus Benmelstobart and AG in First-line Treatment of Advanced Metastatic Pancreatic Cancer (ALTER-PA-001)

Gemcitabine Hydrochloride, Cisplatin, Nab-Paclitaxel, and Durvalumab in Treating Patients with Locally Advanced or Metastatic Gallbladder Cancer

Liposomal Irinotecan in Combination With Oxaliplatin and S-1 Versus Gemcitabine Combined With Capecitabine as Postoperative Adjuvant Therapy for Pancreatic Cancer

NEOLANGIO

Low-dose Gemcitabine and Cisplatin and PD-1/PD-L1 Antibody Therapy in Intrahepatic Cholangiocarcinoma

Irinotecan Liposome，Albumin Paclitaxel and Gemcitabine First-line Treatment for Pancreatic Cancer

A Study of the Treatment of Disitamab Vedotin in Patients With Locally Advanced or Metastatic Pancreatic Cancer

FD-IMPACT

Surufatinib Combined With Gemcitabine Plus Nab-paclitaxel in Locally Advanced Pancreatic Cancer

Comparing Astragalus Plus Gemcitabine to Gemcitabine Alone as Neoadjuvant Treatment for Pancreatic Cancer Patients

HR070803 in Combination With Oxaliplatin, 5-fluorouracil/LV Versus GX as Adjuvant Therapy for Pancreatic Cancer

Surufatinib and Serplulimab Combined With AG Regimen Compare With AG Regimen as Conversion Therapy for Patients With Locally Advanced Pancreatic Cancer (SAGE)

AG Combined With Immunotherapy and SBRT in Patients With Potentially Resectable Pancreatic Cancer

Canagliflozin With Gemcitabine in Pancreatic Carcinoma